Final decision on granting clearance to Covaxin next week: WHO
Hyderabad, Oct. 5 -- Officials from the World Health Organisation (WHO) and an independent group of experts will meet next week to carry out a risk/benefit assessment and take a final decision on whether to grant 'Emergency Use Listing' to Hyderabad-based Bharat Biotech's Covaxin as a safe and effective vaccine against the COVID-19 virus.
"Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional info at WHO's request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week," the WHO said in a series of tweets on Tuesday.
The 'Emergency Use Listing' process by the WHO and the Technical Advisory G...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.